These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

614 related items for PubMed ID: 18422606

  • 1. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE.
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [Abstract] [Full Text] [Related]

  • 2. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
    Mannix LK, Loder E, Nett R, Mueller L, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Cephalalgia; 2007 May; 27(5):414-21. PubMed ID: 17448179
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
    Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Feb; 48(2):226-35. PubMed ID: 18005144
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P.
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [Abstract] [Full Text] [Related]

  • 5. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R, Rizatriptan Protocol 059 and 061 Study Groups.
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R, Crawford G, Ahrens S, Hairwassers D, Getson A, Visser WH, Lines C, Rizatriptan-RPD Study Group.
    MedGenMed; 2001 Jun 01; 3(3):1. PubMed ID: 11549974
    [Abstract] [Full Text] [Related]

  • 9. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF, Foley KA, Barlas S, Solomon G, Hu XH.
    Clin Ther; 2006 Jun 01; 28(6):872-80. PubMed ID: 16860170
    [Abstract] [Full Text] [Related]

  • 10. Early treatment of migraine with rizatriptan: a placebo-controlled study.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2004 Jun 01; 44(7):669-73. PubMed ID: 15209688
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis.
    Ho TW, Rodgers A, Bigal ME.
    Headache; 2009 Mar 01; 49(3):395-403. PubMed ID: 19222588
    [Abstract] [Full Text] [Related]

  • 13. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J, García-Moncó C, Roig C, Yusta Izquierdo A, López-Gil A, eMAX Study Group.
    Headache; 2005 Oct 01; 45(9):1140-50. PubMed ID: 16178944
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb 01; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]

  • 16. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J, Tiseo PT, Albert KS, Li C, Sikes CR.
    Headache; 2006 Feb 01; 46(7):1142-50. PubMed ID: 16866718
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
    Mateos V, Roig C, López Rodríguez I, López-Gil A.
    Neurologia; 2002 Dec 01; 17(10):621-7. PubMed ID: 12487957
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
    Cady R, Martin V, Mauskop A, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2006 Jun 01; 46(6):914-24. PubMed ID: 16732837
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP, Cady RK.
    Clin Ther; 2007 Jun 01; 29 Suppl():2511-9. PubMed ID: 18164918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.